Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

A vow by the agency’s new commissioner, Marty Makary, to support innovation might ease fears stoked by Health and Human ...

The global marketplace is here to stay. But global competition must take place on fair, transparent and enforceable terms, ...

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the impact of mass layoffs at the FDA, impact on ...

Third Harmonic Bio is going to shut down, should shareholders accept a plan by directors to liquidate the San Francisco ...

Find out how you can mitigate risks when expanding your biotech business internationally in the current tariff and trade ...

Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

Zurich-based startup Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, ...

Biotech entrepreneur Sam Waksal has been accused of "reckless conduct," including using a veterinary medicine on a severely ...

Switzerland's Xlife Sciences AG said on Wednesday its portfolio company, VERAXA Biotech AG, will merge with Voyager Acquisition in a deal that will value the combined company at $1.64 billion.

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

GenScript Biotech Corporation, a global leader in biotechnology research services, and NSG Bio, Singapore's premier biotech ...